67
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Ludipress as a “Multipurpose Excipient” for Direct Compression: Part II: Interactive Blending and Tableting with Micronized Glibenclamide

&
Pages 2927-2952 | Published online: 20 Oct 2008
 

Abstract

In the second part of this publication the differing interactions of micronized glibenclamide during mixing with four filler/binders for direct compression were studied. The excipients used were: Ludipress, Cellactose, Avicel PH 200 and Karion Instant. In order to prepare interactive mixtures, increasing amounts of micronized glibenclamide were blended with filler/binder fractions of 125 to 500 μm. The degree of interactivity was determined by air jet sifting of the mixes, comparing drug content in the mixes before and after sieving. Cellactose showed the highest adhesion tendency for glibenclamide due to the large cavities in the particles, leading to a reagglomeration within these cavities. Tablets containing 1.75, 3.50, 5.00 and 10.00 mg of glibenclamide per tablet were compressed with Cellactose and Ludipress. As previously reported (1) for Cellactose based placebo tablets, Cellactose also showed a tremendous increase in disintegration time and a prolonged dissolution rate at compaction pressures above 100 MPa. The corresponding values of Ludipress were not influenced. Therefore in terms of a multipurpose-excipient, Ludipress should be given preference in the formulation of low dosed drugs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.